PPAR gamma agonists thiazolidinediones (TZDs) are insulin sensitizing molecules and some of them are used in the type 2 diabetes treatment (Picard and Auwerx, 2002; Rangwala and Lazar, 2004). Here, PPARG is linked to type 2 diabetes mellitus.